Invention Application
- Patent Title: EGFR INHIBITOR COMPOUNDS
-
Application No.: PCT/US2017/034163Application Date: 2017-05-24
-
Publication No.: WO2017205459A8Publication Date: 2017-11-30
- Inventor: BUNKER, Kevin, Duane , HUANG, Peter, Qinhua , ABRAHAM, Sunny , PINCHMAN, Joseph, Robert , HOPKINS, Chad, Daniel , SLEE, Deborah, Helen
- Applicant: ZENO ROYALTIES & MILESTONES, LLC
- Applicant Address: 10835 Road To The Cure Suite 205 San Diego, CA 92121 US
- Assignee: ZENO ROYALTIES & MILESTONES, LLC
- Current Assignee: ZENO ROYALTIES & MILESTONES, LLC
- Current Assignee Address: 10835 Road To The Cure Suite 205 San Diego, CA 92121 US
- Agency: MILLER, Kimberly J.
- Priority: US62/342,141 20160526
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D209/04 ; A61K31/404 ; A61P35/00
Abstract:
Disclosed herein are nitrogen-containing bicyclic compounds, together with pharmaceutical compositions and methods of ameliorating and/or treating a cancer described herein with one or more of the compounds described herein.
Public/Granted literature
- WO2017205459A1 EGFR INHIBITOR COMPOUNDS Public/Granted day:2017-11-30
Information query
